Novartis' Tafinlar/Mekinist combo gets FDA nod for anaplastic thyroid cancer

Novartis' Tafinlar/Mekinist combo gets FDA nod for anaplastic thyroid cancer  Pharmaceutical Business Review Combo Therapy OK'd for Aggressive Thyroid Cancer  Newsmax FDA Approves Combo Therapy for BRAF-Positive Anaplastic Thyroid Cancer  Specialty Pharmacy TimesFull coverage

Read More ...
Novartis' Tafinlar/Mekinist combo gets FDA nod for anaplastic thyroid cancer published May 07, 2018 at 03:48PM. Original Source Link : http://regulatoryaffairs.pharmaceutical-business-review.com/news/novartis-tafinlarmekinist-gets-fda-nod-for-anaplastic-thyroid-cancer-070518-6141122

loading...